Loading clinical trials...
Loading clinical trials...
A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke
Conditions
Interventions
Albumin
Saline
Locations
89
United States
Mayo Clinic Hospital
Phoenix, Arizona, United States
University of Arizona Medical Center-South Campus
Tucson, Arizona, United States
University of Arizona Medical Center
Tucson, Arizona, United States
John Muir Medical Ctr-Concord
Concord, California, United States
El Camino Hospital
Mountain View, California, United States
UCSF Medical Center
San Francisco, California, United States
Start Date
June 1, 2006
Primary Completion Date
February 1, 2013
Completion Date
February 1, 2013
Last Updated
December 17, 2019
NCT07371455
NCT07253181
NCT06990867
NCT07001267
NCT07004673
NCT03153683
Lead Sponsor
University of Miami
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions